comparemela.com

Latest Breaking News On - Omniab company profile - Page 4 : comparemela.com

OmniAb, Inc (NASDAQ:OABIW) Short Interest Update

OmniAb, Inc. (NASDAQ:OABIW – Get Free Report) saw a large drop in short interest during the month of September. As of September 30th, there was short interest totalling 6,600 shares, a drop of 42.6% from the September 15th total of 11,500 shares. Based on an average daily trading volume, of 18,600 shares, the days-to-cover ratio […]

Head to Head Review: OmniAb (OABI) & Its Rivals

OmniAb (NASDAQ:OABI – Get Free Report) is one of 40 publicly-traded companies in the “Commercial physical research” industry, but how does it compare to its competitors? We will compare OmniAb to related businesses based on the strength of its dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Profitability This table compares OmniAb and […]

Contrasting OmniAb (OABI) & Its Competitors

OmniAb (NASDAQ:OABI – Get Free Report) is one of 39 public companies in the “Commercial physical research” industry, but how does it contrast to its peers? We will compare OmniAb to related companies based on the strength of its risk, analyst recommendations, earnings, profitability, valuation, dividends and institutional ownership. Valuation and Earnings This table compares […]

Reviewing OmniAb (OABI) & Its Rivals

OmniAb (NASDAQ:OABI – Get Free Report) is one of 39 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its peers? We will compare OmniAb to related companies based on the strength of its risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 58.7% of […]

Critical Comparison: OmniAb (OABI) & Its Rivals

OmniAb (NASDAQ:OABI – Get Free Report) is one of 37 public companies in the “Commercial physical research” industry, but how does it compare to its peers? We will compare OmniAb to related businesses based on the strength of its valuation, analyst recommendations, risk, institutional ownership, dividends, profitability and earnings. Earnings & Valuation This table compares […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.